Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc effect on latent HIV-1 transcription in resting CD4+ T cells
2012-003215-66Phase 2Completed
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of maraviroc in human immunodeficiency virus infection (HIV), sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal. Primary endpoint: Quantification of cytoplasmic HIV-1 RNA. Started Jul 2012; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2012-003215-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003215-66.